Увійти

Готові списки джерел за темами / Forns index / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Forns index.

Статті в журналах з теми "Forns index"

Автор: Grafiati

Опубліковано: 3 червня 2025

Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Forns index".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Dr., Abdul Rahim Memon *. Dr. Nand Lal Seerani Dr. Majid Ali Soomro Dr. Imran Karim Dr. Ramon A. Docobo and Dr. Samreen. "FORNS INDEX TO PREDICT FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE." Indo American Journal of Pharmaceutical Sciences 04, no. 11 (2017): 4362–65. https://doi.org/10.5281/zenodo.1064341.

Повний текст джерела

Анотація:

Objective: To estimate the Forns index to predict fibrosis in patients with chronic liver disease at tertiary care hospital Patients and Methods: Total Fifty patients, of 12 to 50 years either gender had chronic liver disease by positive HCV RNA PCR and/or HBsAg, and had liver biopsy done for evaluation purposes were enrolled and entered in this six months cross sectional study after informed consent. The brief history was taken and relevant clinical examination was performed while the laboratory investigations include latelet count, γ-glutamyl transferase (GGT), and cholesterol levels.

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Siregar, Rizqi Arini, Leonardo Basa Dairi, and Gontar Alamsyah Siregar. "Forns index as a useful noninvasive predictor of esophageal varices in liver cirrhosis." Universa Medicina 35, no. 3 (2016): 199. http://dx.doi.org/10.18051/univmed.2016.v35.199-205.

Повний текст джерела

Анотація:

Background<br />Rupture and bleeding from esophageal varices are major complications of portal hypertension and associated with a high mortality rate. Non-invasive serum markers of liver fibrosis could be used as predictors of esophageal varices in cirrhotic patients. The objective of this study was to assess the performance of Forns index as a noninvasive predictor in diagnosing esophageal varices.<br /><br />Methods<br />A cross-sectional study was done in 51 cirrhotic patients who were admitted to Adam Malik hospital, Medan. Demographic and clinical data were recorde

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Faghih Dinevari, Masood, Mohammad Hossein Somi, Mohammad Kazem Tarzamni, et al. "The diagnostic value of non-invasive serum liver fibrosis indices in the prediction of portal hypertension in cirrhotic patients: a cross-sectional study." Journal of Research in Clinical Medicine 8, no. 1 (2020): 23. http://dx.doi.org/10.34172/jrcm.2020.023.

Повний текст джерела

Анотація:

Introduction: Considering that portal hypertension is principally caused by hepatic fibrosis, some studies postulated the predictive value of serum liver fibrosis indices in the diagnosis of portal hypertension. In this study we assessed the prognostic value of serum indices in the diagnosis of portal hypertension in cirrhotic patients. Methods: One hundred two cirrhotic patients were selected according to inclusion/exclusion criteria. Cirrhosis and the Child-Pugh score was determined by the gastroenterologist. Portal hypertension was diagnosed by the radiologist using the color Doppler method

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Ballestri, Stefano, Alessandro Mantovani, Enrica Baldelli, et al. "Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease." Diagnostics 11, no. 1 (2021): 98. http://dx.doi.org/10.3390/diagnostics11010098.

Повний текст джерела

Анотація:

Liver fibrosis predicts liver-related and cardiovascular outcomes in chronic liver disease patients. We compared the diagnostic performance of various liver fibrosis biomarkers for identifying histological significant/advanced fibrosis. Additionally, the correlations of such liver fibrosis biomarkers with cardiovascular risk (CVR) scores were evaluated. 173 patients with viral hepatitis (157 HCV and 16 HBV) and 107 with a non-alcoholic fatty liver disease (NAFLD) were consecutively enrolled. Various liver fibrosis biomarkers: aspartate aminotransferase (AST) to alanine aminotransferase (ALT) r

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Ballestri, Stefano, Alessandro Mantovani, Enrica Baldelli, et al. "Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease." Diagnostics 11, no. 1 (2021): 98. http://dx.doi.org/10.3390/diagnostics11010098.

Повний текст джерела

Анотація:

Liver fibrosis predicts liver-related and cardiovascular outcomes in chronic liver disease patients. We compared the diagnostic performance of various liver fibrosis biomarkers for identifying histological significant/advanced fibrosis. Additionally, the correlations of such liver fibrosis biomarkers with cardiovascular risk (CVR) scores were evaluated. 173 patients with viral hepatitis (157 HCV and 16 HBV) and 107 with a non-alcoholic fatty liver disease (NAFLD) were consecutively enrolled. Various liver fibrosis biomarkers: aspartate aminotransferase (AST) to alanine aminotransferase (ALT) r

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Stepanov, Yu M., V. I. Didenko, I. A. Klenina, O. M. Tatarchuk, and O. P. Petishko. "Improvement of liver fibrosis verification using new minimally invasive markers in patients with chronic diffuse liver diseases." Medicni perspektivi 27, no. 4 (2022): 100–114. http://dx.doi.org/10.26641/2307-0404.2022.4.271181.

Повний текст джерела

Анотація:

The aim of our research was to obtain new minimally invasive serum markers of fibrotic changes of liver in patients with chronic diffuse liver diseases of different etiology and compare them with traditional markers. 364 patients aged 30 to 66 years were examined: 221 women (60.7%) and 143 men (39.3%). Depending on the etiological factors, all patients were divided into 4 groups: group I consisted of 108 patients with non-alcoholic fatty liver disease (NAFLD), group II – 143 patients with chronic hepatitis associated with virus C (CHC), group III – 56 patients with alcoholic liver disease (ALD

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Stepanov, Yu.M., V.I. Didenko, I.A. Klenina, O.M. Tatarchuk, and O.P. Petishko. "Improvement of liver fibrosis verification using new minimally invasive markers in patients with chronic diffuse liver diseases." Medicni perspektivi 27, no. 4 (2022): 100–114. https://doi.org/10.26641/2307-0404.2022.4.271181.

Повний текст джерела

Анотація:

The aim of our research was to obtain new minimally invasive serum markers of fibrotic changes of liver in patients with chronic diffuse liver diseases of different etiology and compare them with traditional markers. 364 patients aged 30 to 66 years were examined: 221 women (60.7%) and 143 men (39.3%). Depending on the etiological factors, all patients were divided into 4 groups: group I consisted of 108 patients with non-alcoholic fatty liver disease (NAFLD), group II – 143 patients with chronic hepatitis associated with virus C (CHC), group III – 56 patients with alcoholic liver

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Moriya, Kei, Shinya Sato, Norihisa Nishimura, et al. "Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis." Journal of Clinical Medicine 12, no. 13 (2023): 4463. http://dx.doi.org/10.3390/jcm12134463.

Повний текст джерела

Анотація:

Background/Aims: The search for noninvasive biomarkers that can efficiently estimate the extent of liver fibrosis progression is ongoing. Although Fibrosis-4 (FIB-4), the aspartate transaminase-to-platelet ratio index (APRI), and the Forns index have been reported as useful biomarkers, their investigation in autoimmune hepatitis (AIH) is limited. This study aimed to examine the usefulness of these serological indices and a newly developed index in predicting liver fibrosis progression in AIH. Methods: The study analyzed data from 190 patients diagnosed with AIH at our institution between 1990

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Chrostek, Lech, Dagmara Przekop, Ewa Gruszewska, Monika Gudowska-Sawczuk, and Bogdan Cylwik. "Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics." BioMed Research International 2019 (May 5, 2019): 1–9. http://dx.doi.org/10.1155/2019/3646975.

Повний текст джерела

Анотація:

The aim of this study was to evaluate the diagnostic values of noninvasive indirect markers of liver fibrosis: APRI, GAPRI, Forns, FIB-4, Age-Platelet, and Hepascore in alcoholics. Blood samples were collected from a randomized group of 142 alcohol-dependent patients. The diagnosis of dependency was made according to the ICD-10 WHO criteria. The values of noninvasive markers were calculated with specific algorithms. The fibrosis stage was evaluated on the basis of FibroTest. The values of APRI, Forns, FIB-4, GAPRI, AP, and Hepascore differ between various stages of liver fibrosis. Patients wit

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Milovanovic, Tamara, Ana Copertino, Ivan Boricic, et al. "Transient elastography for noninvasive assessment of liver fibrosis in patients with primary biliary cirrhosis." Vojnosanitetski pregled 75, no. 4 (2018): 374–79. http://dx.doi.org/10.2298/vsp160409337a.

Повний текст джерела

Анотація:

Backgrund/Aim. In recent decades noninvasive methods for the assessment and monitoring of liver fibrosis have been developed and evaluated in numerous chronic liver diseases. The aim of this study was to evaluate the diagnostic accuracy of noninvasive markers for fibrosis assessment transient elastography (TE) and biochemical markers using liver biopsy as reference in patients with primary biliary cirrhosis (PBC). Methods. One hundred and twenty-two patients underwent both liver biopsy and blood tests on the same day and TE in a month following the biopsy and the tests. Liver biopsies were rev

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Izumi, Gaku, Atsuhito Takeda, Hirokuni Yamazawa, et al. "Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion." Heart and Vessels 35, no. 4 (2019): 586–92. http://dx.doi.org/10.1007/s00380-019-01515-w.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Reese, Lindsey J., Diane S. Tider, Alicia C. Stivala, and Dawn A. Fishbein. "Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection." AIDS Research and Treatment 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/978790.

Повний текст джерела

Анотація:

Background. Liver fibrosis is accelerated in HIV and hepatitis C coinfection, mediated by profibrotic effects of angiotensin. The objective of this study was to determine if angiotensin converting enzyme inhibitors (ACE-Is) attenuate liver fibrosis in coinfection.Methods. A retrospective review of 156 coinfected subjects was conducted to analyze the association between exposure to ACE-Is and liver fibrosis. Noninvasive indices of liver fibrosis (APRI, FIB-4, Forns indices) were compared between subjects who had taken ACE-Is and controls who had not taken them. Linear regression was used to eva

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Romero-Cristóbal, Mario, Ana Clemente-Sánchez, Patricia Piñeiro, et al. "Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients." Therapeutic Advances in Gastroenterology 14 (January 2021): 175628482110234. http://dx.doi.org/10.1177/17562848211023410.

Повний текст джерела

Анотація:

Background: Coronavirus disease (COVID-19) with acute respiratory distress syndrome is a life-threatening condition. A previous diagnosis of chronic liver disease is associated with poorer outcomes. Nevertheless, the impact of silent liver injury has not been investigated. We aimed to explore the association of pre-admission liver fibrosis indices with the prognosis of critically ill COVID-19 patients. Methods: The work presented was an observational study in 214 patients with COVID-19 consecutively admitted to the intensive care unit (ICU). Pre-admission liver fibrosis indices were calculated

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Rao, Jian-Guo, Yu-Feng Gao, Jun Ye, Yan-Yan Wei, Fang Li, and Gui-Zhou Zou. "Value of Forns index for noninvasive diagnosis of liver fibrosis in chronic hepatitis B patients." World Chinese Journal of Digestology 23, no. 11 (2015): 1818. http://dx.doi.org/10.11569/wcjd.v23.i11.1818.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Servais Albert Fiacre, Eloumou Bagnaka, Bekolo Nga Winnie Tatiana, Nsenga Djapa Guy Roger, et al. "Evaluation of liver fibrosis by non-invasive markers (transient elastography vs. APRI, FIB-4, and FORNS) in chronic hepatitis C virus carriers in a low-income country." Nigerian Journal of Gastroenterology and Hepatology 16, no. 1 (2024): 22–28. http://dx.doi.org/10.4103/njgh.njgh_3_24.

Повний текст джерела

Анотація:

Abstract Background: The interest in evaluating hepatic fibrosis stems from the fact that the risk of developing cirrhosis following hepatitis C virus (HCV) infection is estimated at 10%–20%. The aim of this study was to identify feasible, accessible, and affordable non-invasive methods other than transient elastography (TE) in the evaluation of liver fibrosis in a resource-limited country. Materials and Methods: This was a cross-sectional analytical study conducted over 24 months in two health facilities in Douala, Cameroon. All chronically infected HCV patients who had undergone a TE were en

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Przekop, Dagmara, Jakub Klapaczynski, Agnieszka Grytczuk, et al. "Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C." Journal of Clinical Medicine 10, no. 17 (2021): 3951. http://dx.doi.org/10.3390/jcm10173951.

Повний текст джерела

Анотація:

The effectiveness of interferon-free therapy during the course of HCV infection has already been confirmed. Liver fibrosis can be assessed in several ways, from biopsies to imaging tests. The present study evaluates the usefulness of non-invasive indirect biomarkers of liver fibrosis (APRI, GAPRI, FORNS, FIB-4, the AP index and HUI score) as markers of the effective treatment of HCV with the 3D regimen. Blood samples were collected from 70 patients suffering from chronic hepatitis C. Patients received the 3D AbbVie regimen for hepatitis C. All patients had HCV genotype 1b. The APRI, GAPRI, FIB

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Dong, Chang-Feng, Jia Xiao, Ling-Bo Shan, et al. "Combined acoustic radiation force impulse, aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B." World Journal of Hepatology 8, no. 14 (2016): 616. http://dx.doi.org/10.4254/wjh.v8.i14.616.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Yin, Jing-Ya, Tian-Yuan Yang, Bing-Qing Yang, et al. "FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis." World Journal of Gastroenterology 30, no. 18 (2024): 2440–53. http://dx.doi.org/10.3748/wjg.v30.i18.2440.

Повний текст джерела

Анотація:

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) with hepatic histological NAFLD activity score ≥ 4 and fibrosis stage F ≥ 2 is regarded as “at risk” non-alcoholic steatohepatitis (NASH). Based on an international consensus, NAFLD and NASH were renamed as metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), respectively; hence, we introduced the term “high-risk MASH”. Diagnostic values of seven non-invasive models, including FibroScan-aspartate transaminase (FAST), fibrosis-4 (FIB-4), aspartate transaminase to platele

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Gorban, V. V., E. V. Matveeva, E. V. Gorban, and E. S. Kameneva. "The possibilities of transabdominal sonographic diagnosis of liver and intestinal lesions in comorbid gastroesophageal reflux disease." Meditsinskiy sovet = Medical Council, no. 15 (October 6, 2022): 134–43. http://dx.doi.org/10.21518/2079-701x-2022-16-15-134-143.

Повний текст джерела

Анотація:

Introduction. The spread of gastroesophageal reflux disease (GERD), comorbid with non-alcoholic fatty liver disease, requires modification of methods for non-invasive diagnosis of liver steatosis and fibrosis and concomitant gastrointestinal syndromes.Aim. Substantiation of a modified complex outpatient transabdominal sonographic diagnosis of combined lesions of the liver and intestines in comorbid GERD.Materials and methods. 165 outpatients with GERD (mean age 40.4 ± 2.9 years) underwent clinical and laboratory examinations, ultrasound examination (UE) of the gastrointestinal tract (GIT), liv

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Thévenot, Thierry, Sophie Vendeville, Delphine Weil, et al. "Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study." PLOS ONE 17, no. 5 (2022): e0266965. http://dx.doi.org/10.1371/journal.pone.0266965.

Повний текст джерела

Анотація:

Although coronary artery disease (CAD) and advanced liver fibrosis (AdLF) are commonly associated in patients with non-alcoholic fatty liver disease (NAFLD), the prevalence of AdLF and the diagnostic performance of non-invasive fibrosis tests (NITs) in CAD patients remains unknown. We aimed to prospectively screen for AdLF in patients with documented CAD using NITs and Fibroscan. High and intermediate zones of NITs were combined to define AdLF. AdLF was suspected whenever APRI ≥ 0.5, Forns index ≥ 4.2, NAFLD fibrosis score (NFS) ≥ -1.455/0.12 for age </≥ 65 yrs), Fib4 (≥ 1.30/2.0 for age &l

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Choi, Won-Mook, Jeong-Hoon Lee, Hongkeun Ahn, et al. "Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection." Liver International 35, no. 8 (2015): 1992–2000. http://dx.doi.org/10.1111/liv.12776.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Tsai, Tsung-Ying, Pai-Feng Hsu, Cheng-Hsueh Wu, et al. "Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores." Nutrients 14, no. 15 (2022): 3163. http://dx.doi.org/10.3390/nu14153163.

Повний текст джерела

Анотація:

Background: The severity of nonalcoholic fatty liver disease (NAFLD) has been found to be associated with atherosclerosis burden. However, whether liver fibrosis scores can be used to predict atherosclerosis progression, especially for patients with low calcium scores, remains undetermined. Methods: A total of 165 subjects who underwent repeated coronary computed tomography angiography (CCTA) and had low calcium scores (<100) were enrolled. The segment stenosis score (SSS) from the CCTA was measured, and the association between SSS progression and biochemical parameters was analyzed in addi

Стилі APA, Harvard, Vancouver, ISO та ін.

23

GUZELBULUT, Fatih, Zuleyha AKKAN CETINKAYA, Mesut SEZIKLI, Bulent YASAR, Selvinaz OZKARA, and Ayse Oya KURDAS OVUNC. "AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C." Turkish Journal of Gastroenterology 22, no. 3 (2011): 279–85. http://dx.doi.org/10.4318/tjg.2011.0213.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Hassan, Eman M., Dalia A. Omran, Mohamad L. El Beshlawey, Mahmoud Abdo, and Ahmad El Askary. "Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?" Gastroenterología y Hepatología 37, no. 2 (2014): 58–65. http://dx.doi.org/10.1016/j.gastrohep.2013.09.008.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Saranskaya, Yana, Lyubov Kiseleva, and Larisa Il'mukhina. "OPTIONS OF INTERFERON-FREE THERAPY FOR HCV INFECTION. A CASE STUDY. COMPARISON OF NON-INVASIVE METHODS FOR LIVER FIBROSIS ASSESSMENT." Ulyanovsk Medico-biological Journal, no. 1 (April 20, 2022): 39–48. http://dx.doi.org/10.34014/2227-1848-2022-1-39-48.

Повний текст джерела

Анотація:

The incidence of hepatitis C virus infection in Russia is 2–3 %. In our country the socio-economic damage caused by the increase in the incidence of chronic hepatitis and its consequences, such as liver cirrhosis and hepatocarcinoma, is enormous. The goal of antiviral therapy for chronic hepatitis C is a sustained virological response, which is associated with a biochemical response and regression of hepatic tissue fibrosis, which leads to a decrease in the liver cirrhosis development. The purpose of the study is to determine the efficacy of interferon-free therapy; to compare the effica

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Fragkos, Konstantinos C., María Claudia Picasso Bouroncle, Shankar Kumar, et al. "Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study." Nutrients 12, no. 7 (2020): 2151. http://dx.doi.org/10.3390/nu12072151.

Повний текст джерела

Анотація:

(1) Background: Intestinal failure-associated liver disease (IFALD) in adults is characterized by steatosis with variable progression to fibrosis/cirrhosis. Reference standard liver biopsy is not feasible for all patients, but non-invasive serological and quantitative MRI markers for diagnosis/monitoring have not been previously validated. Here, we examine the potential of serum scores and feasibility of quantitative MRI used in non-IFALD liver diseases for the diagnosis of IFALD steatosis; (2) Methods: Clinical and biochemical parameters were used to calculate serum scores in patients on home

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Kayadibi, Huseyin, Bulent Yasar, Selvinaz Ozkara, Muhittin A. Serdar, Oya O. Kurdas, and Can Gonen. "The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis." Scandinavian Journal of Clinical and Laboratory Investigation 74, no. 3 (2014): 240–47. http://dx.doi.org/10.3109/00365513.2013.879392.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Heyens, Leen, Hanna Kenjic, Pieter Dagnelie, et al. "Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study." BMJ Open Gastroenterology 11, no. 1 (2024): e001466. https://doi.org/10.1136/bmjgast-2024-001466.

Повний текст джерела

Анотація:

ObjectiveGlucose metabolism status (GMS) is linked to non-alcoholic fatty liver disease (NAFLD). Higher levels of advanced glycation end products (AGEs) are observed in people with type 2 diabetes mellitus (T2DM) and NAFLD. We examined the association between GMS, non-invasive tests and AGEs, with liver steatosis and fibrosis.MethodsData from The Maastricht Study, a population-based cohort, were analysed. Participants with alcohol overconsumption or missing data were excluded. GMS was determined via an oral glucose tolerance test. AGEs, measured by skin autofluorescence (SAF), were assessed us

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Salama, Mohamed, Manal Nomir, Maryan Fahmi, Amal El-Gayar, and Mamdouh El-Shishtawy. "Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma." Scientia Pharmaceutica 86, no. 4 (2018): 44. http://dx.doi.org/10.3390/scipharm86040044.

Повний текст джерела

Анотація:

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. In an attempt to understand some potential mechanisms of persistence and oncogenicity of Hepatitis C virus (HCV)-related HCC, microfibrillar-associated protein 4 (MFAP4), fibrotic indices and oxidative status biomarkers were assessed in the sera of 50 patients with HCV-associated HCC, 25 patients with HCV-related liver cirrhosis and 15 healthy individuals. Serum oxidized Coenzyme Q10 (CoQ10) and malondialdehyde showed significant elevation in HCC patients compared to the control group (p < 0.00

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Ballestri, Stefano, Alessandro Mantovani, Maria Di Girolamo, Enrica Baldelli, Mariano Capitelli, and Amedeo Lonardo. "Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality." Metabolism and Target Organ Damage 3, no. 1 (2023): 1. http://dx.doi.org/10.20517/mtod.2022.23.

Повний текст джерела

Анотація:

Liver fibrosis is critical for liver-related outcomes and mortality in chronic liver disease, irrespective of etiology, including nonalcoholic fatty liver disease (NAFLD). NAFLD has been viewed as an independent correlate of cardiovascular risk. This review article briefly describes the cellular and molecular pathomechanisms underlying hepatic fibrosis. We then address noninvasive assessment of liver fibrosis. Finally, we discuss published evidence supporting fibrosis biomarkers’ role in assessing cardiovascular risk among patients with NAFLD. While histological assessment is the diagnostic st

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Resino, Salvador, Cristina Asensio, José María Bellón, et al. "Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: A validation study." Journal of Infection 63, no. 5 (2011): 402–5. http://dx.doi.org/10.1016/j.jinf.2011.07.017.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Yang, Mei, Lina Jiang, Yijin Wang, et al. "Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease." Journal of Gastrointestinal and Liver Diseases 28, no. 3 (2019): 289–96. http://dx.doi.org/10.15403/jgld-420.

Повний текст джерела

Анотація:

Background and Aims: Liver fibrosis is stage-dependently associated with non-alcoholic fatty liver disease (NAFLD) progression. The increased awareness of non-invasive diagnosis has led to the establishment of many fibrosis diagnosis models with various accuracies. We aimed to evaluate the diagnostic performance of nine clinical non-invasive fibrosis models in NAFLD and provide an optimal diagnostic method for advanced fibrosis by step layered combination of non-invasive models. Methods: 453 consecutive patients with biopsy-proven NAFLD were enrolled from three centers and were divided i

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Alboraie, Mohamed, Marwa Khairy, Marwa Elsharkawy, Noha Asem, Aisha Elsharkawy, and Gamal Esmat. "Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus." Hepatology Research 45, no. 5 (2014): 560–70. http://dx.doi.org/10.1111/hepr.12385.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Caviglia, Gian Paolo, Giulia Troshina, Umberto Santaniello, et al. "Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals." Cancers 14, no. 3 (2022): 828. http://dx.doi.org/10.3390/cancers14030828.

Повний текст джерела

Анотація:

Patients with hepatitis C virus (HCV)-related cirrhosis treated with direct-acting antivirals (DAA) are still at risk of developing hepatocellular carcinoma (HCC). We investigated the accuracy of non-invasive scoring systems (NSS) for the prediction of de novo HCC development in patients treated with DAA on long-term follow-up (FU). We analyzed data from 575 consecutive patients with cirrhosis and no history of HCC who achieved a sustained virologic response (SVR) to DAA therapy. NSS (i.e., Forns index, APRI, FIB-4, ALBI, and aMAP) were calculated at 3 months after the end of therapy. Performa

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Adler, Michael, Béatrice Gulbis, Christophe Moreno, et al. "The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases." Hepatology 47, no. 2 (2008): 762–63. http://dx.doi.org/10.1002/hep.22085.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Liu, Jianxue, Yafeng Li, Xueliang Yang, et al. "Comparison of Two-Dimensional Shear Wave Elastography with Nine Serum Fibrosis Indices to Assess Liver Fibrosis in Patients with Chronic Hepatitis B: A Prospective Cohort Study." Ultraschall in der Medizin - European Journal of Ultrasound 40, no. 02 (2019): 237–46. http://dx.doi.org/10.1055/a-0796-6584.

Повний текст джерела

Анотація:

Abstract Purpose To prospectively assess liver fibrosis with two-dimensional shear wave elastography (2D-SWE) in patients with chronic hepatitis B (CHB) and to compare the performance of this modality with that of serum indices using Scheuer scoring from liver biopsies as the reference standard. Materials and Methods 123 patients with CHB underwent 2D-SWE measurements and serological tests between April 2016 and February 2018. The 2D-SWE and serum indices in the diagnosis of liver fibrosis were assessed using receiver operating characteristic (ROC) analyses. Results The areas under ROC (AUCs)

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Delle Monache, Marco, Alessio Petrelli, Alessandra Rossi, et al. "Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy." Canadian Journal of Infectious Diseases and Medical Microbiology 2021 (August 14, 2021): 1–7. http://dx.doi.org/10.1155/2021/3068690.

Повний текст джерела

Анотація:

Background. Noninvasive methods are useful for investigating patients with chronic HBV infection. The severity of liver disease in inactive HBsAg carriers can be noninvasively assessed by transient elastography (TE) alone or in association with biochemical markers of fibrosis. Objectives. The study evaluates the effectiveness of the TE compared to common fibrosis scores (FSs), APRI, Forns Index, and FIB4, for identifying significant fibrosis in Italian and foreigner HBsAg carriers. To investigate the risk of progression of the liver disease, liver stiffness (LS) and HBV-DNA were monitored over

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Khan, Mohammad Qasim, Vijay Anand, Norbert Hessefort, et al. "Utility of electronic medical recordbased fibrosis scores in predicting advanced cirrhosis in patients with hepatitic C virus infection." Journal of Translational Internal Medicine 5, no. 1 (2017): 43–48. http://dx.doi.org/10.1515/jtim-2017-0011.

Повний текст джерела

Анотація:

Abstract Objective To determine whether advanced cirrhosis - defined by the detection of nodular liver contours or portal venous collaterals on imaging studies - could be predicted by fibrosis algorithms, calculated using laboratory and demographic features extracted from patients’ electronic medical records. To this end, we compared seven EMR-based fibrosis scores with liver imaging studies in a cohort of HCV patients. Methods A search of our health system’s patient data warehouse identified 867 patients with chronic HCV infection. A total of 565 patients had undergone at least one liver imag

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Liu, Menglu, Kaibo Mei, Ziqi Tan, et al. "Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis." Canadian Journal of Gastroenterology and Hepatology 2022 (March 29, 2022): 1–11. http://dx.doi.org/10.1155/2022/7235860.

Повний текст джерела

Анотація:

Background and Aim. The relationship between liver fibrosis scores and clinical outcomes in patients with COVID-19 is not compressively assessed. Methods. We identified relevant cohort studies that assessed the relationship between liver fibrosis scores (e.g., FIB-4, NAFLD fibrosis score (NFS), and aspartate aminotransferase to platelet ratio index (APRI)) and associated prognosis outcomes by searching the PubMed, EMBASE, and medRxiv databases. The potential dose-response effect was performed using a stage robust error meta-regression. Results. Sixteen studies with 8,736 hospitalized patients

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Fandler-Höfler, Simon, Rudolf E. Stauber, Markus Kneihsl, et al. "Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke." Therapeutic Advances in Neurological Disorders 14 (January 2021): 175628642110372. http://dx.doi.org/10.1177/17562864211037239.

Повний текст джерела

Анотація:

Background: Liver fibrosis has been identified as an outcome predictor in cardiovascular disease and has been associated with hematoma expansion and mortality in patients with primary intracerebral hemorrhage. We aimed to explore whether clinically inapparent liver fibrosis is related to neurological outcome, mortality, and intracranial hemorrhage risk in ischemic stroke patients after mechanical thrombectomy. Methods: We included consecutive patients with anterior circulation large vessel occlusion stroke treated at our center with mechanical thrombectomy between January 2011 and April 2019.

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Rusin, A. V., and O. P. Balazh. "SPECIAL METHODS OF DIAGNOSIS OF THE FUNCTIONAL CONDITION OF THE LIVER IN PATIENTS WITH CIRRHOSIS." Kharkiv Surgical School, no. 5-6 (December 14, 2020): 8–13. http://dx.doi.org/10.37699/2308-7005.5-6.2020.02.

Повний текст джерела

Анотація:

Abstract. The aim. Using special methods to investigate the functional state of the liver in patients with cirrhosis. Materials and methods. The study involved 95 patients with LC who were hospitalized from 2018 to 2020 in the Department of Anesthesiology and Intensive Care, Surgical and Gastroenterological Departments of the Transcarpathian Regional Clinical Hospital. Andriy Novak (Uzhhorod). All patients underwent C13-metacetin breath test (C13-MDT) to determine the degree of liver damage. To determine the degree of fibrosis in the examined patients used the following specially develop

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Bencardino, S., F. D’Amico, R. Barà, et al. "P1181 Liver fibrosis predicts response to advanced therapy in inflammatory bowel disease: a new personalized treatment approach?" Journal of Crohn's and Colitis 19, Supplement_1 (2025): i2151—i2152. https://doi.org/10.1093/ecco-jcc/jjae190.1355.

Повний текст джерела

Анотація:

Abstract Background Crohn's disease (CD) and ulcerative colitis (UC) are chronic and progressive inflammatory bowel diseases (IBD). It is estimated that up to 30-50% of patients with IBD develop intestinal fibrosis leading to complications such as strictures. Liver fibrosis occurs up to 16.7% of patients with IBD. However, the impact of liver fibrosis on the response to therapy in patients with IBD is unknown. Our aim was to investigate the association between liver fibrosis before starting an advanced therapy and response to treatment in IBD. Methods We conducted a retrospective analysis of d

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Androutsakos, Theodoros, Maria Schina, Abraham Pouliakis, Athanasios Kontos, Nikolaos Sipsas, and Gregorios Hatzis. "Liver Fibrosis Assessment in a Cohort of Greek HIV Mono-Infected Patients by Non-Invasive Biomarkers." Current HIV Research 17, no. 3 (2019): 173–82. http://dx.doi.org/10.2174/1570162x17666190809153245.

Повний текст джерела

Анотація:

Background: Non-alcoholic Fatty Liver Disease (NAFLD) is common in HIV-infected individuals. Liver biopsy remains the gold-standard procedure for the diagnosis of liver fibrosis, but both Transient Elastography (TE) and Non-invasive Biomarkers (NIBMs) have emerged as alternatives. Objectives: Our study’s aim was to validate commonly used NIBMs for the assessment of liver fibrosis in a cohort of Greek HIV-mono-infected patients. Methods: Inclusion criteria were confirmed HIV-infection and age>18 years and exclusion criteria HBV or HCV seropositivity, liver disease other than NAFLD, alcohol a

Стилі APA, Harvard, Vancouver, ISO та ін.

44

DONG, DAO-RAN, MEI-NA HAO, CHENG LI, et al. "Acoustic radiation force impulse elastography, FibroScan®, Forns’ index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods." Molecular Medicine Reports 11, no. 6 (2015): 4174–82. http://dx.doi.org/10.3892/mmr.2015.3299.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Zhang, Qingqing, Qidi Zhang, Binghang Li, et al. "The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B." Mediators of Inflammation 2021 (March 1, 2021): 1–11. http://dx.doi.org/10.1155/2021/6636947.

Повний текст джерела

Анотація:

Background and Aim. miRNAs play an important role in the development of human fibrosis. However, miRNA expression profiles during different stages of chronic hepatitis B (CHB) are not well defined. In this study, we aimed to further validate the features of 5 miRNA candidates from our previous study during different fibrotic stages and the value of diagnosis for liver fibrosis. Methods. Differential expression of five selected miRNAs (hsa-mir-1225-3p, hsa-mir-1238, hsa-miR-3162-3P, hsa-miR-4721, and hsa-miR-H7) was verified by qRT-PCR in the plasma of 83 patients and 20 healthy controls. The r

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Semmler, Georg, Sebastian Bachmayer, Sarah Wernly, et al. "Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease." PLOS ONE 15, no. 12 (2020): e0244514. http://dx.doi.org/10.1371/journal.pone.0244514.

Повний текст джерела

Анотація:

Background Nut consumption has been associated with reduced inflammation, insulin resistance, and oxidative stress. However, the influence on the prevalence and severity of non-alcoholic fatty liver disease (NAFLD) has yet to be evaluated. Methods 4655 subjects were included as part of a colorectal carcinoma screening program (SAKKOPI) between 07/2010 and 07/2019 and analyzed 2020. Patients were characterized using biochemical and metabolic parameters, as well as a detailed questionnaire on dietary habits. The diagnosis of NAFLD was established using abdominal ultrasound. Consumption of nuts w

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Varisco, Sofia. "Formas de resistencia, experiencias y organización etnopolítica de una comunidad mapuche en provincia de Buenos Aires, Argentina." Investigación & Desarrollo 32, no. 2 (2024): 63–92. http://dx.doi.org/10.14482/indes.32.02.519.958.

Повний текст джерела

Анотація:

Objetivo: Analizar desde una perspectiva etnográfica los procesos étnicos-identitarios y la organización etnopolítica de la población indígena en la localidad de Carhué, provincia de Buenos Aires (Argentina). Para ello fueron atendidas diversas cuestiones, como las estrategias, los reclamos y las formas de resistencia llevadas a cabo por las familias que la componen. En este análisis resulta central atender a la emergencia étnica de la década de 1990 en espacios urbanos y las legislaciones que tienen como principales destinatarios a los pueblos originarios del país. Materiales y métodos: El tr

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Woolwine, David, and Dario Mendez. "‘I am not a professional indexer, I am a professional who indexes’: periodical indexing as a borderland profession." Indexer 43, no. 2 (2025): 131–46. https://doi.org/10.3828/index.2025.15.

Повний текст джерела

Анотація:

In response to Andrew Abbott’s (1988 , 1995 ) work on professionalization and Gil Eyal’s (2013) work on the sociology of expertise, and employing grounded theory as a method, we propose that some forms of expert labor in knowledge organization (periodical indexing and related activities) are not fully captured by established professions. Rather, these activities permanently exist in a borderland between professions. Two types of borderland are discussed: structural and identity/consciousness. We draw upon borderland theory, which has its origins in Chicano studies and anthropology, to explicat

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Пальцев, И. В., and А. Л. Калинин. "Clinical and Laboratory Parameters for Assessingthe Effect of the Hemochromatosis Gene on Metabolic Manifestations of Liver Pathology in Hepatitis C." Лабораторная диагностика. Восточная Европа, no. 1 (March 22, 2021): 51–57. http://dx.doi.org/10.34883/pi.2021.10.1.006.

Повний текст джерела

Анотація:

Введение. Хронический гепатит С (ХГС) является достаточно широко распространенным заболеванием инфекционной природы, нередко приводящим к формированию цирроза печени. Одним из факторов, влияющих на его развитие, является ген гемохроматоза. Простая гетерозиготная мутация H63D гена гемохроматоза (ген HFE) рассматривается одной из наиболее распространенных в человеческой популяции и в большинстве случаев не оказывает влияния на метаболизм. Литературные сведения о влиянии данной мутации на лабораторные показатели у пациентов с ХГС противоречивы.Цель. Сравнительная оценка метаболических изменений у

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Verma, R. K., R. Kumar, and H. Chauhan. "Status of Plant Diversity in Alpine Pasture of Chansel of District Shimla, Himachal Pradesh." Ecology, Environment and Conservation 29 (2023): 355–63. http://dx.doi.org/10.53550/eec.2023.v29i03s.064.

Повний текст джерела

Анотація:

A study to evaluate the floristic diversity and growth forms in alpine pasture of Chansel of district Shimla, Himachal Pradesh was conducted during August, 2019. Phyto- sociological studies was carried out by laying out quadrates randomly in the selected alpine pasture. The data collected were analyzed for density, frequency, abundance, importantance value index, dominance index, diversity index, distribution pattern, life forms etc., for drawing the logical conclusion. Total numbers of plant species were 100 belonging to 80 genera and 36 families. The plant species comprised of 5 grasses, 1 s

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!